Graham Juan
- SEC CIK
- 0001879223
No open-market purchases or sales filed in the past year.
Current role at each company
- CATX Perspective Therapeutics, Inc.Chief Financial Officeras of Apr 1, 2025
- KYNB Kyntra Bio, Inc.CHIEF FINANCIAL OFFICERas of Dec 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Graham Juan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CATX Perspective Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 (view filing) | Mar 28 | 4 days | Graham JuanChief Financial Officer | PPurchase | +33.3K | $2.25 | +$75.0K | +1,649.3%35.4K after |
KYNB Kyntra Bio, Inc.
CHIEF FINANCIAL OFFICER4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 7 | 2 days | Graham JuanChief Financial Officer | SSale | −1.78K | $16.99 | −$30.3K | −2.4%71.1K after | 2 lots |
| Mar 10, 2023 (view filing) | Mar 8-10 | 2 days | Graham JuanChief Financial Officer | SSale | −7.66K | $20.54 | −$157.4K | −9.5%72.9K after | 4 lots |
| Dec 15, 2022 (view filing) | Dec 9-12 | 6 days | Graham JuanChief Financial Officer | SSale | −2.19K | $14.64 | −$32.0K | −4.4%48.0K after | Amended2 lots |
| Dec 15, 2022 (view filing) | Dec 8 | 7 daysLate | Graham JuanChief Financial Officer | SSale | −5.74K | $14.89 | −$85.5K | −10.3%50.1K after | 2 lots |